Cialis, the drug trademark of Lilly Icos can be beneficial to humans in ways other than treating erectile dysfunction. Clinical studies have found that tadalafil, the main component of Cialis can help people to reduce their blood pressure, keeping the prostrate condition of the area under the control and handling of lung disorders that will come. Additional benefits Cialis has made Lilly Icos brighter future.
David Goodkin, senior vice president at Icos stated in a press release that the company is constantly working for the development of drugs for other potential benefits. Even tadalafil, the active ingredient in Cialis, previously developed as a drug in curing impotence angina before its properties is realized.
Icos announced that they will take advantage of Cialis mechanism for the effective treatment of hypertension or chronic high blood pressure. Goodkin said there are about 50 million people with hypertension in the United States alone. Although many drugs to cure chronic high blood pressure are available, none of them were free of major side effects. Drug Cialis may prove to be a nightmare, with negligible side effects.
Lilly Icos went ahead with phase 2 of the study to investigate the effects of Cialis tadalafil in people with hypertension. The results of this study are clinically meaningful. It is established that tadalafil showed that the effect is compatible with other drugs in the market. The only difference appears in the form of side effects. All other drugs inhibiting sex, while Cialis gives a completely opposite effect.
Tadalafil can also treat symptoms of benign prostatic hyperplasia, prostate problems common. A patient with this problem is given at a dose of tadalafil demonstrated statistically remarkable improvement. Comprehensive health assessment of patients showed that Cialis can be an effective drug for men with benign prostatic hyperplasia.
Pulmonary arterial hypertension is a rare lung problems, which is characterized by increased pressure in the pulmonary artery. People who are diagnosed with this condition rarely survive for more than three years. It usually occurs in people who are under 30 years old, generally causing fatigue, shortness of breath and heart failure. Drugs to treat pulmonary arterial hypertension have adverse effects on the liver. The FDA has approved sildenafil as a potential drug for this condition without the risk of harmful side effects. It has raised the possibility of tadalafil as a treatment.
David Goodkin, senior vice president at Icos stated in a press release that the company is constantly working for the development of drugs for other potential benefits. Even tadalafil, the active ingredient in Cialis, previously developed as a drug in curing impotence angina before its properties is realized.
Icos announced that they will take advantage of Cialis mechanism for the effective treatment of hypertension or chronic high blood pressure. Goodkin said there are about 50 million people with hypertension in the United States alone. Although many drugs to cure chronic high blood pressure are available, none of them were free of major side effects. Drug Cialis may prove to be a nightmare, with negligible side effects.
Lilly Icos went ahead with phase 2 of the study to investigate the effects of Cialis tadalafil in people with hypertension. The results of this study are clinically meaningful. It is established that tadalafil showed that the effect is compatible with other drugs in the market. The only difference appears in the form of side effects. All other drugs inhibiting sex, while Cialis gives a completely opposite effect.
Tadalafil can also treat symptoms of benign prostatic hyperplasia, prostate problems common. A patient with this problem is given at a dose of tadalafil demonstrated statistically remarkable improvement. Comprehensive health assessment of patients showed that Cialis can be an effective drug for men with benign prostatic hyperplasia.
Pulmonary arterial hypertension is a rare lung problems, which is characterized by increased pressure in the pulmonary artery. People who are diagnosed with this condition rarely survive for more than three years. It usually occurs in people who are under 30 years old, generally causing fatigue, shortness of breath and heart failure. Drugs to treat pulmonary arterial hypertension have adverse effects on the liver. The FDA has approved sildenafil as a potential drug for this condition without the risk of harmful side effects. It has raised the possibility of tadalafil as a treatment.
